Skip to Main Content
Home
Search
Study Topics
Glossary
Full Text View
Tabular View
No Study Results Posted
Related Studies
Olanzapine/Fluoxetine Combination Versus Comparator in the Treatment of Bipolar I Depression
This study has been completed.
Study NCT00485771 Information provided by Eli Lilly and Company
First Received: June 11, 2007 No Changes Posted
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Bipolar Disorder
Additional conditions recognized in this trial
Depression
More general conditions related to this trial
Affective Disorders, Psychotic
Behavioral Symptoms
Mental Disorders
Mood Disorders
Interventions listed in this trial
Olanzapine
Fluoxetine
Lamotrigine
More general drug interventions related to this trial
Anticonvulsants
Antidepressive Agents
Antidepressive Agents, Second-Generation
Antiemetics
Antipsychotic Agents
Autonomic Agents
Calcium Channel Blockers
Cardiovascular Agents
Central Nervous System Agents
Central Nervous System Depressants
Gastrointestinal Agents
Membrane Transport Modulators
Molecular Mechanisms of Pharmacological Action
Neurotransmitter Agents
Neurotransmitter Uptake Inhibitors
Peripheral Nervous System Agents
Pharmacologic Actions
Physiological Effects of Drugs
Psychotropic Drugs
Serotonin Agents
Serotonin Uptake Inhibitors
Therapeutic Uses
Tranquilizing Agents
Sponsors listed in this trial
Eli Lilly and Company
Back to top of Main Content
